Radiofrequency ablation (RFA) of Barrett ' s esophagus (BE) is a common strategy for the prevention of esophageal adenocarcinoma (EAC). After RFA, the ablated esophagus heals on acid suppressive therapy, and is re-populated with a stratifi ed squamous epithelium, referred to as " neosquamous epithelium (NSE). " Because the ability of the NSE to protect the underlying tissue from recurrent insult by refl ux is unclear, we assessed the barrier function of NSE by comparing it to that of the native upper squamous epithelium (USE) in subjects having undergone RFA.
INTRODUCTION
Barrett ' s esophagus (BE) is defi ned as the presence of specialized columnar epithelium lining the distal esophagus ( 1, 2 ) . It arises in the setting of gastroesophageal refl ux disease as replacement for the " native " esophageal stratifi ed squamous epithelium. Although structurally and functionally better suited to resist refl ux damage than squamous epithelium ( 3, 4 ) , BE is a premalignant lesion that can progress from metaplasia to dysplasia to esophageal adenocarcinoma (EAC) at rates reported to range from ~ 0.12 % to 0.5 % / year ( 1, 5 ) . One strategy currently employed to prevent BE progression to EAC is endoscopic ablation using radiofrequency ablation (RFA). Th is approach has been demonstrated to decrease the incidence of EAC in subjects with BE and high-grade dysplasia ( 6 ) . Following RFA and while on acid suppressive therapy with proton pump inhibitors (PPIs), ablated segments heal with stratifi ed squamous epithelium, referred to as " neosquamous epithelium (NSE) " to distinguish it from native squamous epithelium ( 1, 6 ) . Although initially limited to eradication of dysplastic BE, there is increasing interest in extending this strategy to those without dysplasia whose risk of EAC is very low ( 7 -9 ) . For RFA to be successful in this latter group will require the long-term stability of the replacement NSE, particularly because the NSE is located in an area highly exposed to acidic and weakly acidic gastric contents from ongoing refl ux. Of concern, recurrence of BE is common, occurring in ~ 25 % of subjects aft er RFA ablation at 3 years of follow-up ( 10 ) .
Claudins are a family of proteins resident in the tight junctions (TJs) of squamous epithelium, which are thought to confer resistance to paracellular transport of ions and other molecules. A total of 24 claudins have been described to date ( 11 ) . Previous work suggests that the claudin profi le, or the composition of the various claudins composing the TJ, decides the compe-
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Biljana Jovov , MD 1 , Nicholas J. Shaheen , MD, MPH 1 tency of this barrier. For instance, squamous epithelium rich in claudin-4 demonstrates high resistance to paracellular diff usion of ions ( 12 ) . Th erefore, the claudin expression profi le might shed light on the quality of the epithelial barrier.
As to date there is limited information on the integrity of NSE ( 13 ) , and particularly on its functional integrity as a barrier against noxious luminal contents, e.g., refl uxed acid, we assessed the barrier function of NSE by comparing it with that of the " native " upper squamous epithelium (USE) in the same patient. Because of the substantial rate of recurrence of BE aft er ablation, we hypothesized that the NSE might exhibit impaired epithelial barrier function, and that this impaired function might in part be explained by an altered claudin profi le compared with nonablated squamous tissue.
METHODS

Patients
Th e integrity of the NSE was prospectively assessed in adult patients who presented to the facilities of the University of North Carolina for endoscopic follow-up of ablated dysplastic BE (equally distributed between low-and high-grade dysplasia) that had been performed using the HALO system (Covidien Medical, Sunnyvale, CA). All patients were maintained on chronic twice-a-day PPIs for at least 6 months before assays and all had complete intact linings of NSE that arose following RFA for dysplastic BE that was at least 3 cm in length. Inclusion criteria required the absence of any apparent residual Barrett ' s epithelium. Paired endoscopic biopsies of healthy-appearing NSE and USE were obtained using Maxi Jaw forceps. USE was taken from the proximal esophagus at either 25 cm from the incisors or at least 5 cm above the upper margin of the BE, whichever was more proximal.
Adult controls were patients endoscoped for clinical indications but without signs or symptoms of esophageal disease and an endoscopically normal-appearing esophagus.
Biopsies were placed in formalin fi xative for light microscopy of hematoxylin -eosin-stained sections and in 2 % paraformaldehyde -2 % glutaraldehyde for electron microscopy. Other biopsies were placed in cold Ringer solution for immediate transfer to the laboratory. Th is study was reviewed and approved by the Institutional Review Board at the University of North Carolina at Chapel Hill.
At the laboratory, biopsies were mounted in mini-Ussing transport chambers to determine the total transepithelial electrical resistance ( R T ) and the mucosal-to-serosal fl ux of fl uorescein as markers of epithelial permeability. R T is a measure of the epithelium ' s resistance to fl ux of ions across it, with higher numbers associated with more resistant epithelium. Fluorescein fl ux assesses the ease with which fl uorescein, a large uncharged molecule, diff uses across the paracellular space, with higher measurements indicating increased diff usion. In some subjects biopsies were fi xed in RNA -later for performance of quantitative reverse transcriptase PCR (qRT-PCR) and, in selected cases, western blots to evaluate the expression of the claudins as representatives of esophageal epithelial TJ proteins.
Quantitative reverse transcriptase PCR
Claudin profi le by qRT-PCR was performed on endoscopic biopsies. In brief biopsies underwent total RNA isolation using RNeasy kits (Qiagen, Valencia, CA) per the manufacturer ' s protocols. RNA was fi rst treated with TURBO DNase (TURBO DNA-free kit, Ambion, Austin, TX) and cDNA synthesized from 2.5 μ g of treated RNA for each tissue sample using Superscript III reverse transcriptase (Invitrogen, Carlsbad, CA). Real-time PCR primers were validated primer sets (QuantiTect Primers Assays, Qiagen). Real-time PCR was performed in triplicate with No-RT control for each sample. Reactions consisted of SYBR Green JumpStartTaq ReadyMix for Quantitative PCR (SigmaAldrich, St Louis, MO), pre-made primers, and 5 μ l of sample (cDNA or control). Amplifi cation was performed in a thermal cycler and following amplifi cation, a melting curve analysis was performed. Th e cycle at which each sample crossed a fl uorescence threshold, C t , was determined and triplicate values for each cDNA averaged. Eef1a1 served as a control gene for normalization between samples. ZO-1 showed a constant relationship to Eef1a1 in all samples and was also considered a non-changing control. To simplify reporting, gene expression was normalized to ZO-1 expression. Relative expression values were calculated as 2 Δ C t setting the expression value of ZO-1 to 1.0. If a sample ' s signal did not rise above threshold within 37 cycles, it was considered not detectable.
Immunoblots
Biopsies for western blots were fl ash frozen in liquid N 2 . Cell debris was removed by a short centrifugation at 5,000 r.p.m. An aliquot of cleared lysate was kept for protein quantitation using the BCA Protein Assay Kit (Pierce Biotechnology, Rockford, IL), and the rest diluted with SDS-Laemmli sample buff er. Methods for electrophoresis and immunoblotting were standard. Antibodies against claudin-4 were purchased from Zymed Laboratories (San Francisco, CA). Secondary antibodies for immunoblots were goat anti-rabbit IRDye 800 (Rockland, Gilbertsville, PA). Signals were detected using an Odyssey Infrared Imaging System (LI-COR, Lincoln, NE).
Permeability studies in mini-Ussing chamber
Biopsies were immersed in ice-cold oxygenated Ringer solution and immediately transported to the research laboratory. Specimens were mounted between Lucite rings (aperture diameter, 2 mm, and square area, 0.0314 cm 2 ) in mini-Ussing chambers (device illustrated in ref. ( 12 ) of adequate size to completely seal the aperture. Two sets of electrodes connected the Ringer solutions to voltage clamps (Voltage Current Clamp, MC6; Physiologic Instruments, San Diego, CA) that enabled direct recording of the transmural electrical potential diff erence (PD) and, by passage of current, the short-circuit current (Isc). Th e total electrical resistance ( R T ) is calculated using Ohm ' s law: PD = Isc × R T . All experiments were conducted under open circuit conditions except when transiently switched to the short circuit state for recording of Isc.
Aft er equilibration for 30 min, basal readings of PD, Isc, and R T were obtained and the fl ux of fl uorescein, 300 molecular weight, (Sigma, St Louis, MO) was determined by adding 1 m M fl uorescein to the mucosal bath and then sampling the mucosal bath to obtain the initial concentration. Th e serosal bath was sampled at zero time and at 45 min intervals. Samples were read for the presence of fl uorescein using a fl uorometer (SLM Amico SPF 500, SLM Instruments, Urbana, IL) and the fl uorescence in the serosal samples divided by the fl uorescence in the luminal bath × 100 to determine the fl ux as percent ( % ) of initial fl uorescein concentration. (Note that the values for fl uorescence were linear over the range measured in these experiments.)
Data are reported as the mean ± s.e.m. Statistical signifi cance was accepted at the P < 0.05 level and determined using the Students t -test for continuous data from paired and unpaired samples and χ 2 2 × 2 table for categorical data.
RESULTS
Patients
Th e integrity of the NSE was assessed in a total of 37 adult patients (29 Caucasian male and 8 Caucasian female, mean age (65.5 ± 7 years) who agreed to allow esophageal biopsies of both NSE and healthy-appearing USE from the esophagus. Endoscopic biopsies of healthy-appearing NSE and USE from the same patients were obtained on average 8.2 ± 2.8 months (range 1 -26 months) following their last RFA treatment. No patient had undergone prior endoscopic mucosal resection and the number of RFA sessions before participation in the study ranged from 1 to 8 with a mean of 3.7 ± 1.6. Subsets of this population participated in diff erent protocols as described below for the individual analyses. Adult controls, ( n = 9, 100 % Caucasian males, aged 66.7 ± 12 years) for healthy distal esophageal epithelium were patients endoscoped for clinical indications but without signs or symptoms of esophageal disease and an endoscopically normal-appearing esophagus.
Morphology
Initially, 13 patients had evaluated hematoxylin-and eosinstained sections from esophageal biopsies of both NSE and USE from the same patients. Biopsies were reviewed blindly by one of the investigators (RCO) and scored as either being positive or negative for the presence of dilated intercellular spaces. Dilated intercellular spaces were present in 13 of 13 (100 % ) biopsies of NSE and in 2 of 13 (15 % ) biopsies of USE, P < 0.05 from the same patients ( Figure 1 ), and this verifi ed in selected cases by performance of transmission electron microscopy ( Figure 1 insert) .
It was also notable that 7 of 13 (54 % ) biopsies of NSE had significant eosinophilia compared with 0 of 13 (0 % ) biopsies of USE, P < 0.05.
Permeability markers
To assess barrier function, paired endoscopic biopsies of NSE and USE were obtained and mounted in mini-Ussing chambers for both measurement of R T and fl uorescein fl ux and these compared with endoscopic biopsies of healthy squamous epithelium from the distal esophagus (controls). Nine subjects had both proximal and distal samples from biopsy of adequate size to be mounted in the chambers. As illustrated in Figure 2a ,b , the mean basal value of R T for NSE (120 ± 45.7 Ω / cm 2 ) was signifi cantly lower than R T for USE (252.9 ± 84.2 Ω / cm 2 ; n = 9, P < 0.05), and for controls (321 ± 42 Ω / cm 2 ; n = 9, P < 0.05). Similarly, fl uorescein fl ux for NSE (0.043 % ± 0.038) was signifi cantly higher than fl ux for USE (0.010 % ± 0.006; n = 8, P < 0.05) and controls (0.010 % ± 0.005; n = 8, P < 0.05). Th ere where no signifi cant diff erence between either R T or fl ux between USE and controls. (Note: although nine paired biopsies were evaluable for R T of NSE and USE, one biopsy was lost during fl ux and so only eight paired biopsies of NSE and USE were evaluable for fl uorescein fl ux.)
Given that R T was signifi cantly lower for NSE than USE, we questioned whether this was a function of time from RFA, i.e., with the lower values of NSE were simply a refl ection of the time needed for complete repair of the epithelium. Th erefore, we plotted the R T values for NSE vs. time from last RFA treatment for all subjects who had assessment of NSE resistance ( n = 18; Figure 3 ). As shown, R T values for healthy-appearing NSE were obtained from 2 to 22 months from their last RFA; however, there was no correlation between time from RFA and value of R T and, specifically, R T did not increase over time from RFA. Moreover, there was 
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of claudins were expressed, most were in small amounts with the exception of claudin-1 whose expression levels exceeded 0.25 % of ZO-1. Claudin-2 and -6 were undetectable. Notably, NSE exhibited signifi cantly lower levels for claudin-4 and -10 than for USE, and we verifi ed by western blot ( Figure 5 ) that the protein expression level of claudin-4 was also lower in NSE than in USE.
DISCUSSION
In the present report, we evaluated the barrier function of NSE as a marker of its integrity and compared it with both the " native " USE from the same patient and to native distal esophageal squamous epithelium from controls with healthy esophagus. Native USE was of interest for comparison because it represents the optimum control for the genetic and biologic potential for barrier function of NSE while allowing for diff erences in environment to be manifest, e.g., exposure to gastric refl uxates and previous ablative therapy. Moreover, native USE in the study proved to be an eff ective surrogate for " healthy " squamous epithelium in that it lacked (in 11 of 13 subjects) dilated intercellular spaces and exhibited mean values for R T and fl uorescein fl ux that were shown to be similar to that of healthy distal esophageal epithelium of controls, and mirrored those we previously published from the distal esophagus of healthy subjects ( 14 ) . When compared with USE and healthy distal esophageal epithelium of controls, we found that NSE exhibited both morphologic and functional abnormalities indicative of defective barrier function. Specifi cally, NSE exhibited dilated intercellular spaces (13 of 13 subjects), and compared with both USE and healthy controls had lower R T and higher fl uorescein fl ux values. Taken together, these features support the presence in 
The transepithelial electrical resistance ( R T ) (upper panel) and fl uorescein fl ux (lower panel) are illustrated for neosquamous epithelium (NSE), native esophageal upper squamous epithelium (USE) from the same patients, and healthy native distal squamous epithelium from subjects without esophageal disease (controls). Note that NSE has signifi cantly lower R T and higher fl uorescein fl ux values than both USE and healthy controls indicating higher paracellular permeability to ions and uncharged molecules, respectively. * P < 0.05 compared with healthy controls. Gene expression relative to ZO-1 Claudins Figure 4 . Claudin gene expression profi les for neosquamous epithelium (NSE) and for native esophageal upper squamous epithelium (USE). Claudin expression levels are referenced to expression levels for ZO-1, which is set at 1.0. Note that expression of claudin-4 and claudin-10 were signifi cantly lower in NSE than in USE, while there was no difference in expression of the most prominently expressed claudin, i.e., claudin-1. Error bars = ((2 % CV ) / 100) × (relative expression). * P < 0.05 compared with USE. NT, not tested.
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A second possibility is that genetic infl uences in these patients predispose them to a functionally defi cient epithelial barrier. If this were the case, it might not be surprising that the NSE would recapitulate the fi ndings in the native epithelium, which may have predisposed the patients to develop BE in the fi rst place. Finally, it is possible that post-RFA epithelium is qualitatively diff erent, and inferior to native tissue. Although the cross-sectional nature of this study makes it impossible to cast light on the pre-ablation tissue, it may be that the epithelium regenerated aft er injury is diff erent than the native tissue. To what degree one or more of these mechanisms may explain our fi ndings is unclear.
Th e implication of this work is that despite PPI therapy, the NSE is a " leaky " epithelial barrier, susceptible to recurrent injury. Th is could presumably be a mechanism for the 20 % or greater recurrence rate of BE seen following ablative therapy ( 6, 19 ) . Indeed, in a study by Kahaleh et al . ( 20 ) the recurrence rate of BE following successful ablation (argon plasma coagulation) has been linked to ongoing acid refl ux by showing that BE recurred in 15 / 18 (83 % ) patients with abnormal (acid) pH monitoring vs. only 1 / 8 patients (12.5 % ) with normal pH monitoring. In addition to recurrence of BE, refl ux damage to NSE may have the potential to destabilize any sub-squamous BE beneath it. Th is might occur either because the loss of barrier function by NSE enables luminal contents greater access to buried BE and / or because the infl ux of infl ammatory cells into the area has byproducts, e.g., oxygen free radicals, prostaglandins, that expose buried BE to promoters of cell turnover and mutagenesis ( 21, 22 ) . In keeping with this concern is the fact that sub-squamous high-grade dysplasia and EAC has been occasionally reported following RFA ( 23 ) and that optical coherence tomography studies suggest that sub-squamous BE may be present in as many as 63 % of patients ( 24 ) .
To explore the basis for the defective barrier in NSE, we compared the TJ expression profi les of 20 claudins in NSE to that of USE in the same patients. Th e results showed that, although claudin-1 levels were not signifi cantly diff erent, NSE had signifi cant reductions in both claudin-4 and claudin-10 compared with USE. Th e decrease in claudin-4 is especially notable, as previous work by our group demonstrated that claudin-1 and claudin-4 were the two dominant TJ proteins in healthy esophageal squamous epithelium ( 4 ) , and that reductions in claudin-4 in tissue culture monolayers are accompanied by both lower R T and increased paracellular permeability to cations ( 25 ) . Moreover, Oshima et al. ( 26 ) demonstrated in a culture model of stratifi ed squamous epithe lium that exposure luminally to high concentrations of acid (pH 2 for 4 h) resulted in increased paracellular permeability, and this in conjunction with a decline in TJ-associated claudin-4. Given that in the present study, the reduction in claudin-4 expression in NSE was paralleled by a reduction in claudin-4 protein on western blot in NSE, this may be a mechanism to account for the defective TJ and increased paracellular permeability to ions in NSE seen in our study. As claudin-4 in squamous epithelium has been shown sensitive to luminal acid ( 26 ) and hydrogen ions are the smallest of cations, these data provide a mechanism for the vulnerability of NSE to the destructive eff ects of luminal acid, as hydrogen NSE of a " leaky " paracellular pathway to ions and uncharged molecules. Moreover, based on the persistence of low R T over periods of up to 26 months following RFA, the defective barrier could not be attributed to the time for repair of the ablated segment with NSE -which, as was standard, took place for all patients on twicea-day PPI therapy.
Th e reason(s) for the defective barrier function of the NSE observed in this study is unclear. At its simplest, this could represent recurrent insult from gastroesophageal refl ux disease. Notably, and despite PPI therapy, the defective barrier in NSE had features similar to the defective barrier function reported in patients with nonerosive refl ux disease, i.e., dilated intercellular spaces, low R T , and high fl uorescein fl ux ( 14 -16 ) . Th is raises the possibility that persistence of the defective barrier function in NSE results from ongoing exposure to acidic and / or weakly acidic refl uxates ( 17 ) . While these subjects were maintained on high dose (twice daily) PPI therapy aft er ablation, a previous report of 24-h pH monitoring in asymptomatic patients with BE demonstrated pathological esophageal exposure in 62 % even while on twice-a-day PPI therapy ( 18 ) . Because the current study does not feature concurrent pH monitoring, the extent to which abnormal acid exposures account for the observed impaired barrier function cannot be assessed with the present data, and await further study. Of note, eosinophilia was noted in the NSE. Whether this is due to ongoing refl ux injury or another process is not clear. . Prestained SDS -polyacrylamide gel electrophoresis standard (wide range; Bio-Rad) was used (red bands). Claudin-4 is shown to be more strongly expressed in USE than NSE.
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ions are able to diff use more freely into the NSE than into normal squamous tissue. In summary, this study demonstrates that patients with NSE have defective barrier function and that this defect persists for long periods despite PPI therapy. Th is defect is manifested by an increase in paracellular permeability to ions, and may be at least partially explained by diminished claudin-4 levels in the TJs of the NSE. Th ese defects could result in a vulnerability of NSE to the destructive eff ects of ongoing exposure to acidic and weakly acidic refl uxates. Further, and by extension, the fi nding of defective barrier function in NSE provides a key element in support of the hypothesis that ongoing exposure to acid refl ux may account for the recurrence of BE following RFA and other ablative techniques and potentially to the continued risk of EAC emerging in sub-squamous BE. Whether these defects are reversible by more intensive medical or surgical therapy remains unclear. Furthermore, the extent to which these changes predispose to recurrence of BE following RFA or other ablative techniques and their implications for risk of neoplasia are not yet determined. Future studies could consider the barrier function of the NSE as a predictor for recurrence of disease following RFA.
